Russia's Fastest CRO and clinical trials in Russia - Synergy Research Group (Synergy). - Home

+++ DECEMBER 2016: THE FIRST PATIENT IS SCREENED IN UKRAINE IN PHASE III STUDY IN PATIENTS WITH ASTHMA UNCONTROLLED WITH HIGH DOSE OF INHALED CORTICOSTEROIDS +++ TWO NEW BE STUDIES WERE STARTED IN DECEMBER +++ NEW PHASE III STUDY IN PATIENTS WITH FACIAL ACNE VULGARIS IS STARTED IN UKRAINE AND GEORGIA +++ NOVEMBER 2016: THREE NEW BE STUDIES STARTED +++ THE FIRST PATIENT IS SCREENED INTO A PHASE III STUDY IN PATIENTS WITH IDIOPATHIC MENORRHAGIA +++ OCTOBER 2016: THE FIRST SITE IS INITIATED IN A PHASE III STUDY IN PATIENTS WITH IDIOPATHIC MENORRHAGIA +++ SEPTEMBER 2016: LAST PATIENT IS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH FUNCTIONAL DYSPEPSIA +++ JULY 2016: THE FIRST PATIENT IS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH OVERACTIVE BLADDER +++ NEW PHASE III STUDY IN POSTMENOPAUSAL WOMEN WITH VMS STARTED +++ JUNE 2016: CLINICAL DATABASE IS LOCKED IN TIME IN THE PHASE III STUDY +++ NEW RETROSPECTIVE NON-INTERVENTIONAL STUDY IN PATIENTS WITH THE ACUTE SKINĀ  INFECTION STARTED +++ THE RUSSIAN AND UKRAINIAN MoH APPROVED OUR PHASE III STUDY IN PATIENTS WITH METASTATIC COLORECTAL CANCER +++ THE FIRST PATIENT IS RANDOMIZED IN UKRAINE INTO PHASE III STUDY IN PATIENTS WITH PRIMARY PROGRESSIVE OR RELAPSE-FREE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS +++

About Us CRO Services Expertise Analytics Why Synergy Contact
[ About Us ] [ CRO Services ] [ Expertise ] [ Analytics ] [ Why?.. ]   [ Contact ]